Business Monitor International has increased the forecast for the size of the pharmaceutical market in Hong Kong for 2019 - raising it to $1.53 B. Currently the market stands at $988 M. By Asia market standards this represents a relatively modest CAGR of 4-4.5%.
The healthcare sector in Hong Kong is reportedly developing rapidly, but I'm still surprised by lower growth estimate given the recent IMS report touting emerging pharma markets hitting growth rates from 14-16%.
Posted by Bruce Lehr April 26th 2010.
Comments